Biotech’s Bounce: Expecting Continued Strength | Investing.com CA

Published on 28 Jun 2022 on Investing.com

The SPDR® S&P Biotech ETF (NYSE:XBI) went through its worst drawdown since its inception—more...

Read the rest of the article

Start tracking your investments with Statfolio

The short percentage in S&P 500’s healthcare companies surged at the end of March from February, ...

Seeking Alpha 12 Apr 2024

The Industrial Select Sector SPDR Fund edged up 0.1%. The Financial Select & ...

Investor's Business Daily 12 Apr 2024

...US Investable Market Information Technology 25/50 Index, which includes information technology...

Bankrate via AOL 12 Apr 2024

Drug shortages in the U.S. continue to grow, with 323 medications in short supply in Q1 2024, the...

Seeking Alpha 11 Apr 2024

The S&P 500’s health care sector (NYSEARCA:XLV), holding a weightage of 12.12% in the S&P 500 ind...

Seeking Alpha 11 Apr 2024

etf.com Top 10 Creations (All ETFs) TickerNameNet Flows ($, mm)AUM ($, mm)AUM % ChangeRSPInvesco ...

etf.com via Yahoo Finance 11 Apr 2024

Select SPDR ETF closed fractionally higher and the Health Care Select Sector SPDR Fund ...

Investor's Business Daily 10 Apr 2024

With limited market penetration for GLP-1 drugs, investors may still have an early opportunity fo...

MarketWatch via Yahoo Finance 10 Apr 2024

Market Analysis by ETF Central covering: . Read ETF Central 's Market Analysis on Investing.com CA.

Investing.com 9 Apr 2024

Designed to provide broad exposure to the Health Care ETFs category of the market, the First Trus...

Zacks via Yahoo Finance 9 Apr 2024